Liaoning Cheng Da Co., Ltd. (600739.SS)
- Previous Close
9.88 - Open
9.91 - Bid 9.88 x --
- Ask 9.89 x --
- Day's Range
9.87 - 9.98 - 52 Week Range
9.03 - 15.05 - Volume
4,585,995 - Avg. Volume
7,397,218 - Market Cap (intraday)
15.114B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
988.00 - EPS (TTM)
0.01 - Earnings Date --
- Forward Dividend & Yield 0.15 (1.52%)
- Ex-Dividend Date Aug 18, 2023
- 1y Target Est
--
Liaoning Cheng Da Co., Ltd. engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles and clothing, as well as trading of bulk commodities, such as coal, steel, and aquatic and agricultural products; and investment in securities, insurance and funds, and other financial service enterprises. It also offers human rabies vaccine and human JE inactivated vaccines, as well as exports its products to Egypt and Thailand; and engages in the investment in medical industry, and medical enterprise management consulting. In addition, the company is involved in the provision of medical, computer software and hardware technology development, technology consulting, technology transfer, technical services; and sale of medical equipment and other businesses. Further, it engages in the mining, production and sale of shale oil; and research and development, design, cutting-edge marketing, multinational procurement, and logistics services. Liaoning Cheng Da Co., Ltd. was founded in 1991 and is based in Dalian, China.
www.chengda.com.cn3,356
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 600739.SS
Performance Overview: 600739.SS
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600739.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600739.SS
Valuation Measures
Market Cap
15.11B
Enterprise Value
20.88B
Trailing P/E
1.14k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.37
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.16%
Return on Assets (ttm)
-0.15%
Return on Equity (ttm)
-0.79%
Revenue (ttm)
11.18B
Net Income Avi to Common (ttm)
17.48M
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
6.79B
Total Debt/Equity (mrq)
45.24%
Levered Free Cash Flow (ttm)
-544.12M